new-generation drug-eluting stent

Original Contribution

Initial Experiences of Percutaneous Coronary Intervention Using a New-Generation Everolimus-Eluting Stent Platform

10/01/2021

James C. Spratt , MD, FRCP, BSc, MBChB;

Simon J. Walsh , MD;

Jonathan Black ;

Nicole Neff ;

Jonathan Brown ;

Monika T. Zmarlicka , PharmD;

Marylee V. Worley , PharmD, BCPS;

Mark S. Spence , MD, FRCP;

Joseph Hong , PharmD;

This was a retrospective study across two United Kingdom centers of 139 patients undergoing PCI of 146 coronary lesions using the Synergy Megatron DES.

This was a retrospective study...

10/01/2021

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

new-generation drug-eluting stent

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products